FDA approves KBroVet chewable tablets for managing canine idiopathic epilepsy.
Amneal has received the Food and Drug Administration’s approval for pyridostigmine bromide ER tablets, 105 mg. PB ER 105 mg tablets are a once-daily, orally administered product indicated for ...
(RTTNews) - Amneal Pharmaceuticals (AMRX) announced it has received FDA approval of its New Drug Application for Pyridostigmine Bromide Extended-Release Tablets USP 105 mg. PB ER 105 mg tablets are a ...
BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), a global pharmaceutical company based in the U.S., today announced that it has received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results